Beyond the inhaler: The respiratory market

About this session

Respiratory medicine is evolving beyond traditional therapies and delivery methods, with novel modalities and emerging targets attracting renewed investment interest. This session explores the changing landscape across asthma, COPD, pulmonary fibrosis, and other conditions, examines what recent data reveals about next-generation approaches, and discusses where partnerships and capital are flowing. As innovation accelerates and market dynamics shift, the session identifies differentiated opportunities and strategic considerations for stakeholders in the respiratory space.

Speakers

• PP

  Pietro Puglisi

  Partner · Claris Ventures

  Moderator

• AA

  Akis Andrianos

  Director, Global Business Development, AIR · Chiesi

  Panelist

• JH

  Jimmie Hofman

  CBO · Vicore Pharma

  Panelist

• CS

  Campbell Stewart

  Principal · Novo Holdings

  Panelist